EP1476118B1 - Method of dispensing pharmaceutical substances - Google Patents
Method of dispensing pharmaceutical substances Download PDFInfo
- Publication number
- EP1476118B1 EP1476118B1 EP02801386A EP02801386A EP1476118B1 EP 1476118 B1 EP1476118 B1 EP 1476118B1 EP 02801386 A EP02801386 A EP 02801386A EP 02801386 A EP02801386 A EP 02801386A EP 1476118 B1 EP1476118 B1 EP 1476118B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- microspheres
- individual
- capsule
- capsules
- canister
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000126 substance Substances 0.000 title description 3
- 239000002775 capsule Substances 0.000 claims abstract description 50
- 239000004005 microsphere Substances 0.000 claims abstract description 29
- 239000013543 active substance Substances 0.000 claims abstract description 20
- 238000011049 filling Methods 0.000 claims abstract description 15
- 238000011068 loading method Methods 0.000 claims abstract description 8
- 230000007246 mechanism Effects 0.000 claims description 4
- 239000003814 drug Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000006187 pill Substances 0.000 description 7
- 238000002483 medication Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 229940000425 combination drug Drugs 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000004793 poor memory Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
- A61J3/074—Filling capsules; Related operations
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
- G07F17/0092—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for assembling and dispensing of pharmaceutical articles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/10—Bar codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/20—Colour codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/30—Printed labels
Definitions
- the present invention relates to the field of dispensing pharmaceutical formulations.
- Medicinal dosage forms (such as tablets or capsules) contain an active substance present in micro- or milli- gram amounts combined with inactive substances which promote physical or chemical stability, ease of handling and identification of the product.
- blister packing be offered as a free service by dispensing pharmacists, putting a number of tablets together in a day-coded package.
- patients are still faced with the same large number of tablets to take, which discourages them from taking their treatment reliably.
- Blister packing is currently performed by only a few dispensing pharmacists as a special service, and is not widely available.
- the present invention therefore seeks to reduce the total number of dose forms ('pills') that patients are required to take daily.
- the present invention provides a device for filling a set of pharmaceutical capsules with microspheres, each containing a predetermined quantity of an active substance, to permit the dosage of each individual active substance in each capsule of the set to be varied to suit the requirements of an individual patient, which device comprises a plurality of loading stations each receiving a canister filled with microspheres of a respective one of the active substances, a programmable metering unit associated with the loading stations for counting programmed numbers of microspheres from the individual canisters, and means for introducing the counted microspheres into the individual capsules of the set.
- EP 0587085 discloses an apparatus for mixing different ingredients to form a dental filling material of the desired composition and colour.
- the materials contemplated include liquids and pastes and are not packaged as microspheres.
- the present invention by relying on the counting of microspheres provides a dispensing pharmacist with the facility to mix in one capsule a combination of different active substances in absolute and relative amounts that are specifically prescribed for the patient by a medical practitioner. Not only can the doses and relative amounts of the active substances be tailored to individual patient requirements in any one set, but the different capsules within a set may contain different doses from one another, enabling a particular drug to be phased in or out over the period during which the capsules of the set are to be taken by the patient. This is referred to as titration.
- such capsules should be prepared and packed in an easily available pack for patients locally in community or hospital pharmacies.
- the capsules, or their packaging if they are blister packed to be marked with a code that permits the contained active substances and their dosage to be determined.
- the canisters should be shaped externally to provide secure mounting onto the device in a predetermined orientation and that their internal shape be such as to ensure accurate delivery of microspheres under gravity.
- the canisters may be formed in two parts that seal hermetically against each other to prevent entry of water vapour or to contain a preservative gas introduced into the canisters. Such sealing of the canisters is also advantageous in that it prevents tampering.
- the filled capsules may additionally be sealed into an 'original pack' for dispensing to patients.
- microspheres In order to meter the correct number of microspheres from a supply canister into an individual capsule, it is possible to use as a programmable counter a reciprocating perforated plate, or an indented wheel, controlled by an indexing stepping mechanism. As an alternative, individual microspheres may be counted optically (by interruption of a light beam) and the flow of microspheres into a capsule may be stopped when the desired number has been reached.
- each capsule or more preferably the blister pack containing several capsules may be suitably encoded, for example by means of a bar code or colour coding.
- the encoded data may be used to identify the dispensing pharmacy, to identify the contained medications, using information stored in a database in the pharmacy.
- microspheres The range of active substances to be formulated in microspheres is potentially wide, but would be most appropriate where the typical dose ranged from micrograms to tens of milligrams.
- the external design of the manufacturers' supply canisters for the microspheres may preferably be of standardised dimensions and mechanisms for sealing/unsealing and encoding so as to ensure secure mounting into the capsule filling device and to allow positive identification of the contents of the canister through a mechanical/electrical/radio/magnetic signalling system adopting a standard code.
- the internal design characteristics of the manufacturers' supply canister for the microspheres may be variable to permit adjustment of storage conditions for an adequate shelf life for the individual active substances.
- the canisters may be filled with an inert gas, masked against entry of light, or coated to prevent water vapour entry.
- the external design of the microsphere supply canisters may suitably incorporate a standardised space for labelling giving visual identification and details of contents.
- the capsule filling device may be controlled by a computer installation that includes a printer and the computer may be programmed to print labels that give details of the dispensing pharmacy, patient name, active substance, manufacturer, expiry date and manufacturers' product codes.
- labels may be self adhesive and prepared for attachment to the original dispensing pack and to the outside of a cardboard box containing treatment supply for a 28 or 30 day period.
- the original dispensing pack containing the individually filled capsules should preferably identify capsules for individual days of the week for ease of treatment compliance.
- Such packs may also conform to standardised dimensions and carry protrusions and/or perforations for engagement with the mechanism of an optional additional device for the extraction of the capsules from the original dispensing pack at the patients home.
- the first may be fully automatic, containing original treatment pack for one month's supply of capsules, with ability to present the dose form to the patient at a preset time with audible tone/voice recording/visual alert.
- the second may be a semi-automatic device for easy removal of the capsule from the original dispensing pack, aiding patients with low sight, reduced manual dexterity or poor memory (prompted by magnifying lens window to view day of the week on the contained original dispensing pack).
- the individual components for implementation of the invention may comprise pre-manufactured pharmaceutical capsules which are separated into component halves.
- the lower-parts may be inserted vertically into strips or wheels which hold twenty eight or fifty six half capsules arranged around the margin of the strip or wheel.
- the wheel or strip is capable of precision mounting into the capsule-filling device to allow precise filling of capsules with microspheres.
- a matching strip or wheel is provided to contain pre-inserted matching top-halves of the capsules. Batch closure of filled capsules is effected by application of opposing strips or wheels containing capsule upper and lower halves.
- the capsule halves may be of different colours (e.g. red, orange, yellow, green, light blue, dark blue, brown, black, white, transparent, and they may have superimposed contrasting colour band(s). In this manner, colour coding may be achieved to allow the origin of the capsules to be identified.
- Alphanumeric codes may alternatively or additionally be pre-printed onto one half of capsule (e.g. 10 characters) and such codes may be standardised to enable national identification.
- the microsphere canister will typically contain sufficient spheres for various doses for multiples of twenty eight capsules. Asymmetric shape can be used to ensure standard orientation into the capsule filling device. Labels printed onto the canister can be encoded to allow details of manufacturer, active substance, dose, batch, product licence number and expiry date, to be transferred automatically via a reader in the loading station. The canister is sealed until insertion into the capsule filling device for security against loss of microsphere or contamination of contents.
- the capsule filling device should be able to carry plastic strips or wheels containing 28 or 30 capsules and to allow mounting of up to ten manufacturers' canisters of microspheres.
- the filling device is microprocessor controlled for accurate dispensing of appropriate numbers of each type of microsphere into each capsule in turn.
- the microprocessor of the filling device should preferably be able to interface with a pharmacy computer to allow transfer of prescribing information without re-keying of prescription data to the device, and despatching of securely encoded data to distant secure database via internet connection from the device, via the pharmacy computer.
- the filling device may also be designed to allow future prescription data entry by barcode read directly off prescription form via the pharmacy computer or downloaded from medical practitioners' systems.
- the invention resides not in the construction of any one of the necessary components but in the provision of a device that affords the pharmacist the flexibility to tailor the composition of the active substances in a set of capsules to the needs of an individual patient, as prescribed by a medical practitioner. In this way, a patient need only swallow one capsule at any one time, thereby ensuring that the patient adheres to the regime specified by the practitioner.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Basic Packing Technique (AREA)
Abstract
Description
- The present invention relates to the field of dispensing pharmaceutical formulations.
- Medicinal dosage forms (such as tablets or capsules) contain an active substance present in micro- or milli- gram amounts combined with inactive substances which promote physical or chemical stability, ease of handling and identification of the product.
- Current European guidance prefers that tablets be sold in 'original dispensing packs' consisting of a metal foil laminated onto a plastic 'blister' sheet, containing a one month supply of individual tablets, affording a useful shelf life.
- Patients with serious conditions such as ischaemic heart disease or congestive heart failure are required to take daily a large number of medications, which frequently results in a failure to comply accurately with the recommended prescription. This can be due to:
- forgetting pills
- confusion with dosing schedules
- unwillingness or fear of consuming large numbers of pills
- errors in taking medications resulting in running out of some pills before others.
- A formal study has shown patients 'encash' prescriptions given by medical practitioners at local pharmacies for approximately 60% of the calculated total necessary number of pills, when given a regular prescription of one single tablet daily. When the prescription is for two pills daily, the encashment rate can fall to only 15%. Taking a sub-optimal number of pills would adversely affect quality of life and also reduce survival prognosis, since many treatments are life-extending, particularly when used in combination.
- To mitigate this problem, it has previously been suggested that blister packing be offered as a free service by dispensing pharmacists, putting a number of tablets together in a day-coded package. However, patients are still faced with the same large number of tablets to take, which discourages them from taking their treatment reliably. Blister packing is currently performed by only a few dispensing pharmacists as a special service, and is not widely available.
- It has further been proposed to manufacture tablets containing fixed dose combinations of two or more active substances. This proposal suffers from the disadvantage that fixed dose combination tablets (typically of two active substances) are recommended only for patients who have previously been stabilised on the individual components. Any particular fixed dose combination made by a manufacturer might be unsuitable or harmful for some patients, by causing metabolic disturbances or excessive or inadequate effects.
- The present invention therefore seeks to reduce the total number of dose forms ('pills') that patients are required to take daily.
- In its broadest aspect, the present invention provides a device for filling a set of pharmaceutical capsules with microspheres, each containing a predetermined quantity of an active substance, to permit the dosage of each individual active substance in each capsule of the set to be varied to suit the requirements of an individual patient, which device comprises a plurality of loading stations each receiving a canister filled with microspheres of a respective one of the active substances, a programmable metering unit associated with the loading stations for counting programmed numbers of microspheres from the individual canisters, and means for introducing the counted microspheres into the individual capsules of the set.
-
EP 0587085 discloses an apparatus for mixing different ingredients to form a dental filling material of the desired composition and colour. The materials contemplated include liquids and pastes and are not packaged as microspheres. - The present invention by relying on the counting of microspheres provides a dispensing pharmacist with the facility to mix in one capsule a combination of different active substances in absolute and relative amounts that are specifically prescribed for the patient by a medical practitioner. Not only can the doses and relative amounts of the active substances be tailored to individual patient requirements in any one set, but the different capsules within a set may contain different doses from one another, enabling a particular drug to be phased in or out over the period during which the capsules of the set are to be taken by the patient. This is referred to as titration.
- Preferably, such capsules should be prepared and packed in an easily available pack for patients locally in community or hospital pharmacies.
- It is important for a medical practitioner or a pharmacist to be able to ascertain the medication previously taken by a patient.
- With this aim in mind, it is possible for the capsules, or their packaging if they are blister packed, to be marked with a code that permits the contained active substances and their dosage to be determined.
- It is preferred that the canisters should be shaped externally to provide secure mounting onto the device in a predetermined orientation and that their internal shape be such as to ensure accurate delivery of microspheres under gravity.
- Conveniently, the canisters may be formed in two parts that seal hermetically against each other to prevent entry of water vapour or to contain a preservative gas introduced into the canisters. Such sealing of the canisters is also advantageous in that it prevents tampering.
- To comply with best practice, the filled capsules may additionally be sealed into an 'original pack' for dispensing to patients.
- In order to meter the correct number of microspheres from a supply canister into an individual capsule, it is possible to use as a programmable counter a reciprocating perforated plate, or an indented wheel, controlled by an indexing stepping mechanism. As an alternative, individual microspheres may be counted optically (by interruption of a light beam) and the flow of microspheres into a capsule may be stopped when the desired number has been reached.
- For proper identification of the capsules, each capsule or more preferably the blister pack containing several capsules may be suitably encoded, for example by means of a bar code or colour coding. The encoded data may be used to identify the dispensing pharmacy, to identify the contained medications, using information stored in a database in the pharmacy.
- It is not essential that the code uniquely identify the contained medications and their dosages. As the dispensing pharmacy is identified, it suffices for the pharmacy to maintain a register giving more details about the medications and conveniently such data could be accessed directly by medical practitioners and hospitals by using the Internet. Alternatively, the information could be held centrally, allowing access by approved individuals in a secure manner.
- As the capsule or dispensing pack codes need not carry individual patient details, confidentiality is preserved.
- The range of active substances to be formulated in microspheres is potentially wide, but would be most appropriate where the typical dose ranged from micrograms to tens of milligrams.
- The external design of the manufacturers' supply canisters for the microspheres may preferably be of standardised dimensions and mechanisms for sealing/unsealing and encoding so as to ensure secure mounting into the capsule filling device and to allow positive identification of the contents of the canister through a mechanical/electrical/radio/magnetic signalling system adopting a standard code.
- The internal design characteristics of the manufacturers' supply canister for the microspheres may be variable to permit adjustment of storage conditions for an adequate shelf life for the individual active substances. For example, the canisters may be filled with an inert gas, masked against entry of light, or coated to prevent water vapour entry.
- The external design of the microsphere supply canisters may suitably incorporate a standardised space for labelling giving visual identification and details of contents.
- Conveniently, the capsule filling device may be controlled by a computer installation that includes a printer and the computer may be programmed to print labels that give details of the dispensing pharmacy, patient name, active substance, manufacturer, expiry date and manufacturers' product codes. Such labels may be self adhesive and prepared for attachment to the original dispensing pack and to the outside of a cardboard box containing treatment supply for a 28 or 30 day period.
- The original dispensing pack containing the individually filled capsules should preferably identify capsules for individual days of the week for ease of treatment compliance. Such packs may also conform to standardised dimensions and carry protrusions and/or perforations for engagement with the mechanism of an optional additional device for the extraction of the capsules from the original dispensing pack at the patients home.
- Two types of extracting device such as described immediately above may be envisaged. The first may be fully automatic, containing original treatment pack for one month's supply of capsules, with ability to present the dose form to the patient at a preset time with audible tone/voice recording/visual alert. The second may be a semi-automatic device for easy removal of the capsule from the original dispensing pack, aiding patients with low sight, reduced manual dexterity or poor memory (prompted by magnifying lens window to view day of the week on the contained original dispensing pack).
- The individual components for implementation of the invention may comprise pre-manufactured pharmaceutical capsules which are separated into component halves. The lower-parts may be inserted vertically into strips or wheels which hold twenty eight or fifty six half capsules arranged around the margin of the strip or wheel. The wheel or strip is capable of precision mounting into the capsule-filling device to allow precise filling of capsules with microspheres. A matching strip or wheel is provided to contain pre-inserted matching top-halves of the capsules. Batch closure of filled capsules is effected by application of opposing strips or wheels containing capsule upper and lower halves.
- The capsule halves may be of different colours (e.g. red, orange, yellow, green, light blue, dark blue, brown, black, white, transparent, and they may have superimposed contrasting colour band(s). In this manner, colour coding may be achieved to allow the origin of the capsules to be identified. Alphanumeric codes may alternatively or additionally be pre-printed onto one half of capsule (e.g. 10 characters) and such codes may be standardised to enable national identification.
- The microsphere canister will typically contain sufficient spheres for various doses for multiples of twenty eight capsules. Asymmetric shape can be used to ensure standard orientation into the capsule filling device. Labels printed onto the canister can be encoded to allow details of manufacturer, active substance, dose, batch, product licence number and expiry date, to be transferred automatically via a reader in the loading station. The canister is sealed until insertion into the capsule filling device for security against loss of microsphere or contamination of contents.
- The capsule filling device should be able to carry plastic strips or wheels containing 28 or 30 capsules and to allow mounting of up to ten manufacturers' canisters of microspheres. The filling device is microprocessor controlled for accurate dispensing of appropriate numbers of each type of microsphere into each capsule in turn. The microprocessor of the filling device should preferably be able to interface with a pharmacy computer to allow transfer of prescribing information without re-keying of prescription data to the device, and despatching of securely encoded data to distant secure database via internet connection from the device, via the pharmacy computer. The filling device may also be designed to allow future prescription data entry by barcode read directly off prescription form via the pharmacy computer or downloaded from medical practitioners' systems.
- As equipment for counting microspheres is already known, for example from
FR 2689092 US 4615165 , it is believed that the mechanical construction of equipment suitable for implementing the invention will be clear to the person skilled in the art without the need for further detailed description. - The invention resides not in the construction of any one of the necessary components but in the provision of a device that affords the pharmacist the flexibility to tailor the composition of the active substances in a set of capsules to the needs of an individual patient, as prescribed by a medical practitioner. In this way, a patient need only swallow one capsule at any one time, thereby ensuring that the patient adheres to the regime specified by the practitioner.
Claims (4)
- A device for filling a set of pharmaceutical capsules with microspheres, each containing a predetermined quantity of an active substance, to permit the dosage of each individual active substance in each capsule of the set to be varied to suit the requirements of an individual patient, which device comprises a plurality of loading stations each receiving a canister filled with microspheres of a respective one of the active substances, a programmable metering unit associated with the loading stations for counting programmed numbers of microspheres from the individual canisters, and means for introducing the counted microspheres into the individual capsules of the set.
- A device as claimed in claim 1, wherein each capsule is formed of two separable parts and the device comprises means for separating the two parts of each capsule from one another and reassembling the two parts after counted microspheres have been introduced into the lower part of the capsule.
- A device as claimed in claim 1 or 2, wherein the metering unit includes a reciprocating perforated plate, or an indented wheel, controlled by an indexing stepping mechanism.
- A device as claimed in any preceding claim, wherein the loading stations have means for identifying the contents of a canister received therein from coding on the canister.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0125064A GB2380937A (en) | 2001-10-18 | 2001-10-18 | Method of dispensing a plurality of medical substances into capsules |
GB0125064 | 2001-10-18 | ||
PCT/GB2002/004631 WO2003032891A1 (en) | 2001-10-18 | 2002-10-14 | Method of dispensing pharmaceutical substances |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1476118A1 EP1476118A1 (en) | 2004-11-17 |
EP1476118B1 true EP1476118B1 (en) | 2011-11-23 |
Family
ID=9924112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02801386A Expired - Lifetime EP1476118B1 (en) | 2001-10-18 | 2002-10-14 | Method of dispensing pharmaceutical substances |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1476118B1 (en) |
AT (1) | ATE534366T1 (en) |
ES (1) | ES2377516T3 (en) |
GB (2) | GB2380937A (en) |
WO (1) | WO2003032891A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7086532B2 (en) | 2003-07-16 | 2006-08-08 | Allergan, Inc. | Titration/compliance pack with increasing doses |
WO2012087492A2 (en) | 2010-12-23 | 2012-06-28 | Tailorpill Technologies, Llc | System and methods for personalized pill compounding |
GB201308935D0 (en) | 2013-05-17 | 2013-07-03 | Slovick David | Counting head for dispensing pharmaceutical substances |
US10327994B2 (en) * | 2016-05-02 | 2019-06-25 | Dose Pack Llc | System and methods for customized medicine dosages in a capsule |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3638688A (en) * | 1970-02-24 | 1972-02-01 | Brunswick Corp | Coded oral solids magazine and dispenser |
IT1203137B (en) * | 1978-11-09 | 1989-02-15 | Facchini Libero | CONTINUOUS MOVING OPERATING MACHINE FOR THE PACKAGING OF PULVERULENT OR GRANULAR PRODUCTS |
BR8300014A (en) * | 1982-01-07 | 1983-08-30 | Uss Eng & Consult | APPLIANCE FOR MANUFACTURE OF LEADING ELEMENT CARTRIDGES |
IT1171950B (en) * | 1983-09-30 | 1987-06-10 | Mg 2 Spa | PROCEDURE FOR THE FEEDING, ORIENTATION, FILLING, CLOSING AND EXPULSION OF CAPSULES AND PLANT THAT IMPLEMENTS THIS PROCEDURE |
JPH0620919B2 (en) * | 1987-06-18 | 1994-03-23 | 日本エランコ株式会社 | Method and device for filling granular material into hard capsule |
FR2689092B1 (en) * | 1992-03-31 | 1994-12-30 | Boiron | Device for counting a determined number of beads or the like, then for grouping them in a container. |
EP0587085A3 (en) * | 1992-09-11 | 1994-09-14 | Ihde Stefan Klaus Alfred | Method and device for dosing and mixing multicomponent material |
SE9600070D0 (en) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
IE970731A1 (en) * | 1997-10-07 | 2000-10-04 | Fuisz Internat Ltd | Product and method for the treatment of hyperlipidemia |
US5960609A (en) * | 1998-06-12 | 1999-10-05 | Microdose Technologies, Inc. | Metering and packaging method and device for pharmaceuticals and drugs |
US6183779B1 (en) * | 1999-03-22 | 2001-02-06 | Pharmascience Inc. | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin |
CA2366791A1 (en) * | 1999-04-06 | 2000-10-12 | Kamal K. Midha | Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second cns stimulant |
JP4902918B2 (en) * | 1999-07-30 | 2012-03-21 | スミスクライン ビーチャム ピー エル シー | Multi-component pharmaceutical dosage form |
BR9905261A (en) * | 1999-09-30 | 2001-07-24 | Libbs Farmaceutica Ltda | A new programmed-release drug association |
DE19951504C2 (en) * | 1999-10-26 | 2002-02-21 | 3M Espe Ag | Mixing device and method |
EP1386251A4 (en) * | 2001-03-02 | 2005-11-23 | Euro Celtique Sa | Method and apparatus for compounding individualized dosage forms |
-
2001
- 2001-10-18 GB GB0125064A patent/GB2380937A/en not_active Withdrawn
-
2002
- 2002-10-14 ES ES02801386T patent/ES2377516T3/en not_active Expired - Lifetime
- 2002-10-14 GB GB0408460A patent/GB2397763A/en not_active Withdrawn
- 2002-10-14 EP EP02801386A patent/EP1476118B1/en not_active Expired - Lifetime
- 2002-10-14 WO PCT/GB2002/004631 patent/WO2003032891A1/en not_active Application Discontinuation
- 2002-10-14 AT AT02801386T patent/ATE534366T1/en active
Also Published As
Publication number | Publication date |
---|---|
EP1476118A1 (en) | 2004-11-17 |
ATE534366T1 (en) | 2011-12-15 |
GB2397763A (en) | 2004-08-04 |
ES2377516T3 (en) | 2012-03-28 |
GB0125064D0 (en) | 2001-12-12 |
GB0408460D0 (en) | 2004-05-19 |
GB2380937A (en) | 2003-04-23 |
WO2003032891A1 (en) | 2003-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7712288B2 (en) | Unified ingestion package and process for patient compliance with prescribed medication regimen | |
JP5081835B2 (en) | Pack, pack method and pack manufacturing apparatus for pharmaceutical products and the like | |
US6848593B2 (en) | Automated portable medication radial dispensing apparatus and method using a carrier tape | |
US7793836B2 (en) | Medicine management methods and apparatus | |
CA2516047A1 (en) | Drug administration kit | |
US20130161207A1 (en) | Child Resistant Packaging for Multi-Prescription Order | |
US11443840B1 (en) | Medication adherence apparatus | |
JP2009520536A5 (en) | ||
KR20070012509A (en) | Universal medication carrier | |
JP2002502779A (en) | Weighing dispensing device | |
US20040064215A1 (en) | Pharmaceutical dispenser system | |
US10327994B2 (en) | System and methods for customized medicine dosages in a capsule | |
US7370795B2 (en) | Medicine management methods and apparatus | |
EP1476118B1 (en) | Method of dispensing pharmaceutical substances | |
US20200165022A1 (en) | An apparatus and method for automated sorting and enveloping of homogeneous and/or heterogeneous substances | |
US20090057183A1 (en) | Medication Dispensing System | |
GB2266978A (en) | An electronic dosage reminder | |
WO2014184781A1 (en) | Counting device for dispensing pharmaceutical substances | |
CN210743084U (en) | Medicine dispenser | |
JP3068718U (en) | Medicine bag | |
US11715552B2 (en) | Medicine dispenser | |
US20220142861A1 (en) | Prescription medicine packaging system and method for using same to provide range of compliance options | |
JP2000043898A (en) | Classified medicine pack and medicine instruction displaying medicine information for classified medicine pack | |
JP4699015B2 (en) | Pharmaceutical time indicator | |
JP2022082343A (en) | Storage method of powdered drug to medicine calendar and packaging table for powdered drug used therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040831 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
17Q | First examination report despatched |
Effective date: 20080711 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 60241631 Country of ref document: DE Effective date: 20120119 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2377516 Country of ref document: ES Kind code of ref document: T3 Effective date: 20120328 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: MEYER & KOLLEGEN |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120224 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120323 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20120223 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 534366 Country of ref document: AT Kind code of ref document: T Effective date: 20111123 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20120824 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 60241631 Country of ref document: DE Effective date: 20120824 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20111123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20121014 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 16 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 17 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20191025 Year of fee payment: 18 Ref country code: NL Payment date: 20191028 Year of fee payment: 18 Ref country code: DE Payment date: 20191101 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20191025 Year of fee payment: 18 Ref country code: FR Payment date: 20191025 Year of fee payment: 18 Ref country code: ES Payment date: 20191113 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20191023 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20191021 Year of fee payment: 18 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 60241631 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20201101 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20201014 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201031 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210501 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201031 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201031 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201014 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201014 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201014 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20220121 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201015 |